Endologix DETOUR2 three-year data strengthen case for percutaneous bypass in complex SFA disease
Read how Endologix DETOUR2 three-year data could reshape complex SFA disease treatment while durability and adoption questions remain.
Read how Endologix DETOUR2 three-year data could reshape complex SFA disease treatment while durability and adoption questions remain.
BD secures EU CE Mark for the Revello vascular covered stent for iliac artery disease. Explore what this device could change for PAD treatment in Europe.